Xencor, Inc. (XNCR): Price and Financial Metrics

Xencor, Inc. (XNCR): $20.48

0.04 (-0.19%)

POWR Rating

Component Grades








Add XNCR to Watchlist
Sign Up

Industry: Biotech




#39 of 360

in industry

XNCR Price/Volume Stats

Current price $20.48 52-week high $30.21
Prev. close $20.52 52-week low $16.49
Day low $20.01 Volume 635,100
Day high $20.63 Avg. volume 708,332
50-day MA $22.04 Dividend yield N/A
200-day MA $21.18 Market Cap 1.25B

XNCR Stock Price Chart Interactive Chart >

Xencor, Inc. (XNCR) Company Bio

Xencor Inc. is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases and cancer. The company was founded in 1997 and is based in Monrovia, California.

XNCR Latest News Stream

Event/Time News Detail
Loading, please wait...

XNCR Latest Social Stream

Loading social stream, please wait...

View Full XNCR Social Stream

Latest XNCR News From Around the Web

Below are the latest news stories about XENCOR INC that investors may wish to consider to help them evaluate XNCR as an investment opportunity.

Xencor (NASDAQ:XNCR) shareholders are up 7.7% this past week, but still in the red over the last three years

Xencor, Inc. ( NASDAQ:XNCR ) shareholders should be happy to see the share price up 19% in the last month. But that is...

Yahoo | December 10, 2023

Xencor to Present at the Piper Sandler 35th Annual Healthcare Conference

PASADENA, Calif., November 21, 2023--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases, today announced that company management will present at the Piper Sandler 35th Annual Healthcare Conference in New York City on Tuesday, November 28, 2023, at 8:00 a.m. ET / 11:00 a.m. PT.

Yahoo | November 21, 2023

Things Look Grim For Xencor, Inc. (NASDAQ:XNCR) After Today's Downgrade

One thing we could say about the analysts on Xencor, Inc. ( NASDAQ:XNCR ) - they aren't optimistic, having just made a...

Yahoo | November 13, 2023

Xencor, Inc. (NASDAQ:XNCR) Q3 2023 Earnings Call Transcript

Xencor, Inc. (NASDAQ:XNCR) Q3 2023 Earnings Call Transcript November 8, 2023 Operator: Good afternoon and thank you for standing by. Welcome to Xencor’s Third Quarter 2023 Conference Call. Please be advised that this call is going to be recorded at the company’s request. Now, I would like to turn the call over to your speaker […]

Yahoo | November 9, 2023

We're Not Very Worried About Xencor's (NASDAQ:XNCR) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Yahoo | November 9, 2023

Read More 'XNCR' Stories Here

XNCR Price Returns

1-mo -11.30%
3-mo N/A
6-mo 6.39%
1-year -29.91%
3-year -54.16%
5-year -36.04%
YTD -3.53%
2023 -18.47%
2022 -35.09%
2021 -8.04%
2020 26.87%
2019 -4.89%

Continue Researching XNCR

Want to see what other sources are saying about Xencor Inc's financials and stock price? Try the links below:

Xencor Inc (XNCR) Stock Price | Nasdaq
Xencor Inc (XNCR) Stock Quote, History and News - Yahoo Finance
Xencor Inc (XNCR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!